By
Chelsea A. Jack
“The capacity for suffering and enjoying things is a
prerequisite for having interests at all, a condition that must be satisfied
before we can speak of interests in any meaningful way,” –Peter Singer
Singer
has argued for the equitable and fair treatment of animals based
on their ability to suffer in ways similar to humans. I wonder if, in some
circumstances, ill pets are treated more humanely in times of crisis than their
human counterparts.
Daniel
Callahan, co-founder of The Hastings Center, has thoughtfully written
on how Americans view cost as a morally acceptable factor in
decision-making when it comes to the death of a pet, but not always the death of a human loved
one. Veterinary doctors are not only willing to explain a patient’s
prognosis, but also the financial costs for a family
choosing among various treatment options for their pet. The reason for this
seems to be that conversations about end-of-life decision-making come more
easily in the context of veterinary care than when the patient in question is a
human loved one. Because medical doctors are often reluctant to talk about end-of-life care with
their patients, conversations about the financial costs of such care do not
occur either. This is not necessarily the case with veterinary care, where, if
anything, vets go out of the way to prepare families for the likelihood of
death – and its costs. With both human and non-human patients facing illness,
the financial costs of care can be startling and deeply upsetting. Callahan has
asked how medical doctors might deliver care options to patients in the way his
family’s vet did: “beautifully integrat[ing] money, medical candor, and
compassion.”
I found
myself considering Callahan’s reflection on the death of his own Cavalier King
Charles as I sat in the waiting room of the VCA Animal Specialty &
Emergency Center in Wappingers Falls, New York a few weeks ago. In no
more than three minutes, my beloved 8-month-old Boxer-Pit mix named Trapper –
after MASH 4077’s Trapper John, MD – ventured away from me with
another canine companion during a cookout with my neighbors. He played leap
frog in-between cars speeding down a nearby highway. When I realized he was
gone, I ran down to the road with an ominous feeling in my gut. After calling
his name for a minute, an adrenaline-charged Trapper came bolting up from the
highway and collapsed at my feet completely out of breath. He had deep
abrasions along his front-left paw, which was visibly knotted, and, as the
adrenaline wore off, he could barely stand, even though he remained stoically
silent with his ears back and eyes locked to my face.
I broke
every speed limit on the way to the emergency care center where Trapper went
into shock and began convulsing. Exchanging worried glances, the nurses quickly
carried him away from me into another room where they attempted to stabilize him.
Immediately,
but kindly, a nurse presented me with a series of consent forms and unsettling
numbers: Was I okay with paying $400-600 to stabilize Trapper? Did I want them
to try and resuscitate Trapper if his heart stopped, even if it meant spending
$500 on a procedure with a success rate around 17 percent? Did I consent to the
three recommended x-rays of his front-left leg, chest, and hips, which would
approach $400 – without factoring in the possibility of further x-rays later
over the next 24 hours? There was a possibility that Trapper would pass away due to
contusions in his lungs – did I want to keep him overnight for monitoring even
if that was another $200? Did I want to see the credit plan offered for 12
months without interest for patients who cannot afford expensive high-quality
care?
Throughout
the whole nightmare, the doctors and nurses presented each decision-making
scenario with at least two options: cost projections for the “ideal” treatment
plan versus the “less-ideal” treatment plan. As I weighed these projections, I
thought how the word “ideal” places a nontrivial degree of guilt onto the
decision-maker who opts for the less-ideal options. It problematically values
the more costly decision as morally preferable, even when this might not
accurately reflect the moral landscape – marked by competing financial
obligations – in which real-time decisions are made.
Individuals
and families (more often than not) cannot isolate an immediate, short-term
moral decision from the other long-term ones lingering in the background. For
example, as I weighed the two treatment plans presented to me, I thought, “I
have signed a lease committing me to pay $X/month. I love my apartment and
cannot legally break this lease agreement, and I cannot emotionally or
financially afford to forfeit my living situation even if it means that Trapper
has to receive the 'less-ideal' treatment plan". As a recent post-grad, I
weighed the costs of fulfilling one long-term goal (i.e. living happily in my
new home) against the costs of fulfilling my obligations to care for Trapper as
my pet who was facing a health crisis. Committed and interdependent moral
agents are forced to make these kinds of decisions every day. In my case, it
was productive to not only have Trapper’s physician initiate a conversation
about our end-of-life preferences, but also address possible treatment options and possible
costs.
Miraculously, Trapper
is expected to make a full recovery and came home
from the emergency care center after 24 hours of observation. I’ll borrow
Callahan’s language to describe my own personal take-away from this ordeal:
Trapper’s care team embodied those qualities that
“we might hope for from a doctor for our care, but by no means yet reliably available” in the
human medical context.
Chelsea is a Research Assistant at The Hastings Center. She graduated with highest distinction from the University of Virginia, where she received a B.A. in political and social thought and anthropology with a minor in bioethics. Her research interests include medical and legal anthropology, political and social theory, bioethics, and contemporary feminist thought.